Browsing Tag
NASDAQ
806 posts
How Starbucks (NASDAQ: SBUX) plans to turn 8,000 China stores into a 20,000-store growth engine with Boyu Capital
Starbucks has finalized its Boyu Capital China joint venture. Read what the new model means for Starbucks growth, margins, and competition.
April 3, 2026
Faraday Future (NASDAQ: FFAI) pushes deeper into robotics as FX Aegis clears U.S. sales certification
Faraday Future’s FX Aegis robot has cleared U.S. certification, but can robotics meaningfully change the FFAI story? Read the full analysis now.
April 3, 2026
Versant Media (NASDAQ: VSNT) buys StockStory to expand CNBC’s AI-driven investing platform
Versant Media Group bought StockStory to boost CNBC’s AI investing tools. Read what the deal means for VSNT, digital growth, and retail investor strategy.
April 2, 2026
Amazon bid puts Globalstar (GSAT) in play as satellite spectrum war heats up
Amazon is in talks to buy Globalstar (NASDAQ: GSAT) for USD 9bn. Here's what the deal means for retail investors, the Apple complication, and the key risks.
April 2, 2026
GLND stock: Greenland Energy eyes first Arctic drill spud in 2026
Greenland Energy (NASDAQ: GLND) targets its first Arctic well in H2 2026. Here is the full retail investor guide to the Jameson Land Basin play, the risks, and the catalyst timeline.
April 2, 2026
Lifeway Foods (NASDAQ: LWAY) posts record 2025 sales as kefir demand lifts margins and resets growth outlook
Lifeway Foods, Inc. posted record 2025 sales and stronger margins. Read why its kefir-led growth story could matter even more in 2026.
April 1, 2026
Can Ondas Holdings Inc. turn stratospheric sensing into a scalable ISR growth engine after the World View acquisition? (Nasdaq: ONDS)
Find out what the World View acquisition means for Ondas Holdings Inc.’s defense platform strategy, contract pipeline, and future revenue visibility.
April 1, 2026
Kodiak Sciences (NASDAQ: KOD) bets Phase 3 momentum and 2027 cash runway can turn pipeline promise into a retina franchise
Kodiak Sciences is chasing a retina comeback with Phase 3 Zenkuda data, a longer cash runway, and major catalysts ahead. Read what happens next.
April 1, 2026
Caris Life Sciences (NASDAQ: CAI) says final Achieve 1 data strengthens the case for Caris Detect, but can MCED execution close the gap?
Caris Life Sciences says final Achieve 1 data strengthens Caris Detect. Read why the MCED opportunity looks bigger, and why execution risk still matters.
April 1, 2026
What Datavault AI Inc.’s Coppercoin launch means for critical minerals finance and investor access (NASDAQ: DVLT)
Find out what Datavault AI Inc.’s Coppercoin launch could mean for copper investing, mining finance, and DVLT’s long-term platform strategy.
March 31, 2026